Blue Bear Ventures
Venture capitalSan Francisco · Pre-Seed–Series A · 5 people tracked
Find your way into Blue Bear Ventures
857 people in our graph share verified history with the Blue Bear Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Co-founder-focused fund for lab-based teams at the health–climate intersection (gene therapy, synthetic biology, batteries), offering deep access to UC Berkeley, UCSF, MIT and Stanford research and scientist-founders.
Source: firm website, verified Aug 7, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 18 of 26 portfolio companiesBiotech ×10Deep Tech ×7Healthtech ×6Medical Devices ×6AI & Machine Learning ×5Hardware ×5Cleantech ×4Energy ×3
HQs:United States×13
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×42 founders×63 founders×1
Where their founders studiedfrom 15 founders with education data
University of California, Berkeley ×4Massachusetts Institute of Technology ×2University of California, Santa Cruz ×2University of Colorado Boulder ×2
Where their founders worked beforefrom 14 founders with career history
UC Berkeley ×4NeuroBo Pharmaceuticals, Inc. ×2Simpatica Medicine, Inc. ×2Ucdavis ×2
Accelerator rootsportfolio companies that came through a program
Investments · 26 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 12019 · 13 dated
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials
Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)
Co-investors4DX VenturesAbstract VenturesArtis VenturesBoxGroupCalm VenturesEvolution VC Partners+9 more
Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases.
Digital HealthHealthtechMedical Devices
Charvi Shetty(Chief Executive Officer)inInderjit Jutla(Chief Scientific Officer)
Co-investorsGood Growth CapitalMatrixRho Capital PartnersRho VenturesZühlke Ventures
Ayar Labs develops co-packaged optics (CPO) technology for AI infrastructure, enabling optical connectivity between thousands of GPUs across data center racks.
AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US
Co-investorsNVIDIAAlumni VenturesBasecamp FundBerkeley FrontierCastor Ventures (an Alumni Ventures Fund)Factorial Funds+16 more
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.
BiotechDigital HealthMedical DevicesSan Carlos, US
Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in
BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues.
BiotechDeep TechMedical Devices
Co-investorsBow CapitalIMM Investment JapanDCVC (Data Collective)
Clarity provides air quality sensing-as-a-service solutions, combining hardware air pollution sensors with cloud-based monitoring software and consulting services for organizations and communities measuring air quality.
CleantechClimate TechData & InfrastructureHardwareIoT
David Lu(Founder)in
BoardMinette NavarreteRamanan RaghavendranMarc Tarpenning
Co-investorsKickstart VenturesSoundproof VenturesSpero VenturesHumba VenturesLMNT VenturesRegeneration.VC
CoreShell Technology develops metallurgical silicon materials for electric vehicle batteries as a more economical and scalable alternative to synthetic silicon.
CleantechEnergyNew Materials
Co-investorsBaruch Future VenturesEntrada VenturesFoothill VenturesHelios Climate VenturesTrousdale VenturesZeon Ventures
Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL.
BiotechDeep TechHardwareHealthtechMedical DevicesSan Francisco, US
Akwasi Apori(Founder)inKursad Araz(Founder/CTO)inSamuel Tia(Founder)in
Co-investorsBeresford VenturesCota CapitalPallasite VenturesPangaea Ventures Us Inc.Y Combinator
Co-investorsBetter Ventures Central LlcSafar PartnersKdT Ventures
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardAndrew Cain McClary(Director)Drew Lanza(Director)
Co-investorsBerkeley CatalystKdT Ventures
Transforming delivery of gene therapies for non-viral, gene editing-based therapeutics.
Kunwoo Lee(Cofounder)
Co-investorsBow Capital
Co-investorsAxial VC
ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions.
AI & Machine LearningBiotechHealthtech
Co-investorsDFJ DragonFundDraper AssociatesHan River PartnersSazze
Lockheed Martin is a global security and aerospace company that develops military aircraft, missile defense systems, helicopters, radar and sensor systems, spacecraft, and cybersecurity capabilities for the U.S.
Deep TechDefense TechHardwareSpace TechBethesda, US
New Sun Road builds Stellar, a microgrid energy management platform combining Microgrid OS and Edge hardware that uses IoT data and AI to monitor, control, and optimize power systems such as solar and battery installations.
CleantechEnergyIoTRichmond, US
Jalel Sager(Director)inAustin Cappon(Director)inCandice Eggerss(Director)Adrienne Pierce(Executive Officer, Director)inChad Riley(Director)
BoardAndrew Karetsky(Director)
Co-investorsSkyview Ventures
Numericcal provides machine learning software for detecting anomalies, tracking assets, and managing workforce activities in automotive and manufacturing facilities, processing video and audio data across on-premises and cloud infrastructure to reduce operating costs.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
Shaoyi Cheng(Founder)inranko sredojevic(Founder)in
Co-investorsY Combinator
Building new drugs to target inflammation using an AI + immunology discovery engine.
BiotechHealthtechSan Francisco, US
Jason Barbour(Founder/CEO)inDavid Ott(Founder/CTO)in
Co-investorsY Combinator
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
BoardVasudev Bailey(Director)in
Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcDroia VenturesFirst Spark Ventures, Llc+6 more
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Co-investorsCivilization Ventures Management, LlcForeground CapitalFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.
BiotechHealthtechMedical DevicesSan Francisco, US
Akash Bakshi(Founder)inNadja Mannowetz(Founder)in
Co-investorsForeground CapitalOlive Tree CapitalPortfoliaY CombinatorFuture VenturesNorth South Ventures+1 more
Portfolio news
latest coverage across their companies
Coreshell · mining-technology.com · Aug 24, 2026
Clarity · finsmes.com · Aug 14, 2026
Resynergi · resynergi.com · Apr 17, 2026
Ayar Labs · reuters.com · Mar 3, 2026
Frequently asked questions
- How many investments has Blue Bear Ventures made?
- Blue Bear Ventures has 26 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Blue Bear Ventures invest at?
- Blue Bear Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Blue Bear Ventures's typical check size?
- Blue Bear Ventures typically writes checks of $100K – $400K.
- What sectors does Blue Bear Ventures focus on?
- Blue Bear Ventures focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, New Materials.
- Where is Blue Bear Ventures located?
- Blue Bear Ventures is headquartered in San Francisco, US.
- Does Blue Bear Ventures lead rounds?
- Blue Bear Ventures typically participates in rounds rather than leading them.
- Who does Blue Bear Ventures co-invest with?
- Blue Bear Ventures most often shares deals with Y Combinator, Abstract Ventures, Artis Ventures, among 72 tracked co-investors.
Media · Podcasts & interviews
featuring the teamDeepak Gupta, Partner Blue Bear Ventures #buildfintechbusiness
FinTech Silicon Valley · Deepak Gupta
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Safar Partners is an early-stage technology investment firm that backs startups spun out of leading research universities, primarily MIT, Harvard, and the University of Rochester.
Fundamental Ventures is an early-stage venture firm that backs founders removing fundamental constraints holding back human progress, spanning hard tech, deep science, and network/workflow innovations.
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.